Samuel A Acquah

Array ( [id] => 8932631 [patent_doc_number] => 08492330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Formulation comprising GLP-1' [patent_app_type] => utility [patent_app_number] => 13/004964 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14762 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13004964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10115776 [patent_doc_number] => 09150647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Biological inhibitors of ROR1 capable of inducing cell death' [patent_app_type] => utility [patent_app_number] => 13/516925 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14766 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767147 [patent_doc_number] => 20120034706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'METHOD FOR ASSESSING INFLAMMATORY CONDITION' [patent_app_type] => utility [patent_app_number] => 12/964077 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3365 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034706.pdf [firstpage_image] =>[orig_patent_app_number] => 12964077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9468985 [patent_doc_number] => 08722615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Compositions and methods for increasing serum half-life' [patent_app_type] => utility [patent_app_number] => 12/959220 [patent_app_country] => US [patent_app_date] => 2010-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20603 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12959220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807332 [patent_doc_number] => 08444982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Anti-IGF-IR antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/955627 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6914 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12955627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202875 [patent_doc_number] => 20110065661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'PHARMACOPERONES FOR CORRECTING DISEASE STATES INVOLVING PROTEIN MISFOLDING' [patent_app_type] => utility [patent_app_number] => 12/953822 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 33032 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065661.pdf [firstpage_image] =>[orig_patent_app_number] => 12953822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429640 [patent_doc_number] => 20120251514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'MODULATED PROGRAMMED DEATH LIGAND-1' [patent_app_type] => utility [patent_app_number] => 13/509476 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19359 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6120880 [patent_doc_number] => 20110077207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'METHOD FOR TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/942302 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12067 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077207.pdf [firstpage_image] =>[orig_patent_app_number] => 12942302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759815 [patent_doc_number] => 08420334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Method for detecting invasive microvesicles derived from tumor cells' [patent_app_type] => utility [patent_app_number] => 12/942858 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 7638 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522678 [patent_doc_number] => 20120322085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES OR ALLERGY, AND METHOD FOR SCREENING FOR THE THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/508192 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29397 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6126616 [patent_doc_number] => 20110086389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Compositions and Methods for Expressing In-Frame Multimeric Proteins' [patent_app_type] => utility [patent_app_number] => 12/915333 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17585 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086389.pdf [firstpage_image] =>[orig_patent_app_number] => 12915333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018512 [patent_doc_number] => 09060981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Marker associated with non-alcoholic steatohepatitis' [patent_app_type] => utility [patent_app_number] => 13/500753 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14322 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634253 [patent_doc_number] => 08012702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'H+-gated ion channel' [patent_app_type] => utility [patent_app_number] => 12/905647 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 11320 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012702.pdf [firstpage_image] =>[orig_patent_app_number] => 12905647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335520 [patent_doc_number] => 20120202222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'ENZYME FRAGMENT COMPLEMENTATION ASSAYS FOR MONITORING THE ACTIVATION OF THE VOLTAGE-GATED POTASSIUM ION CHANNEL HERG' [patent_app_type] => utility [patent_app_number] => 13/501782 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15353 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282697 [patent_doc_number] => 08216798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration' [patent_app_type] => utility [patent_app_number] => 12/896522 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10038 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12896522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608666 [patent_doc_number] => 07993921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Cell cycle regulation and differentiation' [patent_app_type] => utility [patent_app_number] => 12/892760 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 121 [patent_no_of_words] => 32099 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993921.pdf [firstpage_image] =>[orig_patent_app_number] => 12892760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560860 [patent_doc_number] => 20110274692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Screening Methods' [patent_app_type] => utility [patent_app_number] => 12/890590 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 55961 [patent_no_of_claims] => 153 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274692.pdf [firstpage_image] =>[orig_patent_app_number] => 12890590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985652 [patent_doc_number] => 20110097794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/888732 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30712 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097794.pdf [firstpage_image] =>[orig_patent_app_number] => 12888732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301003 [patent_doc_number] => 20120183564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION' [patent_app_type] => utility [patent_app_number] => 13/496313 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6830 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496313 [rel_patent_id] =>[rel_patent_doc_number] =>)